Prevention

Publications

click to view chapters and sections

Disease Control Priorities in Developing Countries (2nd Edition)

1. 1. Investing in Health
   1. HIV/AIDS
   2. Noncommunicable Disease and Injury
   3. Conclusions
2. 2. Intervention Cost–Effectiveness: Overview of Main Messages
   1. Assessing the Evidence on the Cost-Effectiveness of Interventions
3. 5. Science and Technology for Disease Control: Past, Present, and Future
4. 6. Product Development Priorities
5. 8. Improving the Health of Populations: Lessons of Experience
   1. Cases
   2. Intervention Type, Programmatic Characteristics, and Policies
6. 9. Millennium Development Goals for Health: What Will It Take to Accelerate Progress?
   1. Scaling Up: Defining Interventions and Removing Constraints
7. 10. Gender Differentials in Health
   1. Priority Disease Groups for Women
   2. Cost-Effectiveness of Interventions
   3. Research Agenda
8. 11. Fiscal Policies for Health Promotion and Disease Prevention
9. 13. Recent Trends and Innovations in Development Assistance for Health
10. 15. Cost–Effectiveness Analysis for Priority Setting
    1. Definition and Characteristics of Interventions
11. 16. Tuberculosis
12. 17. Sexually Transmitted Infections
    1. Effectiveness of the Principal Interventions
    2. Scaling Up Control Strategies
    3. Research and Development Agenda
13. 18. HIV/AIDS Prevention and Treatment
    1. Obstacles to HIV Control
    2. Action under Uncertainty
    3. Prevention in Theory and Practice: Using Epidemic Profiles and Contextual Factors to Inform Prevention Guidelines
    4. Prevention-Care Synergy
    5. Care and Treatment
    6. Research Agenda
    7. Conclusion
    8. Acknowledgments
14. 19. Diarrheal Diseases
15. 21. Conquering Malaria
    1. Research Priorities
16. 22. Tropical Diseases Targeted for Elimination: Chagas Disease, Lymphatic Filariasis, Onchocerciasis, and Leprosy
    1. Interventions and Their Effectiveness
    2. Costs and Cost-Effectiveness of Interventions
17. 25. Acute Respiratory Infections in Children
    1. Interventions
18. 26. Maternal and Perinatal Conditions
    1. Interventions
19. 27. Newborn Survival
    1. Implementation
20. 28. Stunting, Wasting, and Micronutrient Deficiency Disorders
    1. Interventions
21. 29. Health Service Interventions for Cancer Control in Developing Countries
    1. Types of Interventions for Cancer Control
    2. Cost-Effectiveness of Cancer Control Interventions
    3. Applicability of Cost-Effectiveness Studies from Developed to Developing Countries
    4. Conclusions
22. 30. Diabetes: The Pandemic and Potential Solutions
    1. Research and Development Agenda
23. 32. Neurological Disorders
    1. Stroke
24. 33. Cardiovascular Disease
    1. Research and Development
25. 34. Inherited Disorders of Hemoglobin
    1. Costs and Effectiveness of Diagnosis and Management
26. 35. Respiratory Diseases of Adults
27. 36. Diseases of the Kidney and the Urinary System
    1. Implementation of Control Strategies: Lessons of Experience
    2. Research and Development Agenda
    3. Conclusions: Promises and Pitfalls
28. 37. Skin Diseases
29. 38. Oral and Craniofacial Diseases and Disorders
    1. Dental Caries
    2. Cost-Effectiveness of Oral Health Care
30. 39. Unintentional Injuries
    1. Implementation of Prevention and Control Strategies
31. 40. Interpersonal Violence
    1. Interventions
    2. Cost-Effectiveness of Interventions
    3. Implementation of Prevention Strategies
    4. Conclusions: Promises and Pitfalls
32. 44. Prevention of Chronic Disease by Means of Diet and Lifestyle Changes
    1. Chronic Disease Prevention
33. 45. The Growing Burden of Risk from High Blood Pressure, Cholesterol, and Bodyweight
    1. Interventions
    2. Cost-Effectiveness of Interventions
34. 46. Tobacco Addiction
35. 47. Alcohol
36. 48. Illicit Opiate Abuse
37. 49. Learning and Developmental Disabilities
    1. Three Levels of Prevention
    2. Other Factors Leading to Increases in Measured Prevalence
    3. Interventions in Low- and Middle-Income Countries
    4. Research Agenda for Prevention of Disabilities in Low- and Middle-Income Countries
    5. Summary
38. 50. Loss of Vision and Hearing
    1. Nature, Causes, and Epidemiology of Vision Loss
    2. Nature, Causes, and Epidemiology of Hearing Loss
39. 51. Cost–Effectiveness of Interventions for Musculoskeletal Conditions
    1. Implementation of Control Strategies: Lessons of Experience
40. 53. Public Health Surveillance: A Tool for Targeting and Monitoring Intervention
41. 56. Community Health and Nutrition Programs
42. 58. School–Based Health and Nutrition Programs
43. 59. Adolescent Health Programs
    1. Program Implementation and Lessons of Experience
44. 60. Occupational Health
    1. Economic Aspects of Intervention
45. 61. Natural Disaster Mitigation and Relief
    1. Interventions: From Response to Prevention
    2. Intervention Cost, Cost-Effectiveness, and Economic Benefits
46. 64. General Primary Care
47. 69. Complementary and Alternative Medicine

Global Burden of Disease and Risk Factors

1. 1. Measuring the Global Burden of Disease and Risk Factors, 1990—2001

Priorities in Health

1. 2. Success in Addressing Priorities
2. 3. Cost–Effectiveness Analysis
3. 4. Cost–Effective Strategies for the Excess Burden of Disease in Developing Countries
4. 5. Cost–Effective Strategies for Noncommunicable Diseases, Risk Factors, and Behaviors
   1. Cancer
5. 6. Providing Interventions
   1. Integration of Services Across the Life Cycle
6. 7. Pillars of the Health System